Literature DB >> 11525250

The effects of calcium channel antagonists on short- and long-term retention in mice using spontaneous alternation behavior.

D Quartermain1, V Garcia deSoria.   

Abstract

The effect of calcium channel antagonists (CCA's) on working and reference memory in mice was studied using spontaneous alternation (SA) behavior in a T maze. Mice were given either one or four forced trials to either the right or the left arm on the training session (T1) followed by a free choice test (T2) at varying intervals after the initial trial. Untreated animals given one forced trial exhibited significantly greater levels of SA than chance at all delay intervals out to 20 min but not at 30, 60, or 180 min. Animals given four forced trials showed significant levels of SA 24 h after exposure but not at 72 h. Additional groups of mice were treated with amlodipine, nimodipine, diltiazem, and verapamil 1 h before T1. Mice given one forced trial were tested 30, 60, or 180 min after T1 while mice given four forced trials were tested 72 h after T1. Results showed that all of the CCA's except verapamil produced significant SA at the 30-min interval and nimodipine and diltiazem also significantly increased SA at the 60-min-delay interval. No significant effects were observed at the 180-min test. In the four trial groups, all of the CCA's with the exception of verapamil produced significant levels of SA at the 72-h interval. These results indicate that representative CCA's from both the dihydropyridine and the benzothiazapine classes can facilitate both short- and long-interval SA, thereby providing further confirmation that CCA's can enhance memory processing in young animals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11525250     DOI: 10.1006/nlme.2000.3981

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  5 in total

1.  Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury - A potential therapeutic agent for Alzheimer's Disease.

Authors:  Saravanaraman Ponne; Chinnadurai Raj Kumar; Rathanam Boopathy
Journal:  Metab Brain Dis       Date:  2019-11-05       Impact factor: 3.584

2.  Protective effect of a calcium channel blocker "diltiazem" on aluminum chloride-induced dementia in mice.

Authors:  Anu Rani; Rupinder K Sodhi; Amanpreet Kaur
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-07-05       Impact factor: 3.000

3.  Calcium activated adenylyl cyclase AC8 but not AC1 is required for prolonged behavioral anxiety.

Authors:  Matteo Bernabucci; Min Zhuo
Journal:  Mol Brain       Date:  2016-05-27       Impact factor: 4.041

4.  Verapamil Blocks Scopolamine Enhancement Effect on Memory Consolidation in Passive Avoidance Task in Rats.

Authors:  Verónica Giménez De Béjar; María Caballero Bleda; Natalija Popović; Miroljub Popović
Journal:  Front Pharmacol       Date:  2017-08-23       Impact factor: 5.810

5.  The Oxford study of Calcium channel Antagonism, Cognition, Mood instability and Sleep (OxCaMS): study protocol for a randomised controlled, experimental medicine study.

Authors:  Lauren Z Atkinson; Lucy Colbourne; Alexander Smith; Catherine H Harmer; Anna C Nobre; Jennifer Rendell; Helen Jones; Christopher Hinds; Arne Mould; Elizabeth M Tunbridge; Andrea Cipriani; John R Geddes; Kate E A Saunders; Paul J Harrison
Journal:  Trials       Date:  2019-02-12       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.